Results 121 to 130 of about 2,742,255 (313)
Quality of life of adults with celiac disease
Problemy Pielęgniarstwa, 2021 Alicja Kamińska +2 more
doaj +1 more source
Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism [PDF]
, 2015 Yousef Almehmadi +3 more
openalex +1 more source
The association between acne care provision and quality of life: A cross‐sectional survey [PDF]
, 2022 Femke de Vries +5 more
openalex +1 more source
β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Molecular Oncology, EarlyView.Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero +8 more
wiley +1 more source
Objective, audiological and quality of life measures with the CI532 slim modiolar electrode [PDF]
, 2018 Matthias Hey +12 more
openalex +1 more source
Molecular Oncology, EarlyView.AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source
Psychometric properties of the Specific Thalassemia Quality of Life Instrument for adults
Patient Preference and Adherence, 2012 Georgios N Lyrakos,1,2 Demetra Vini,2 Helen Aslani,2 Marouso Drosou-Servou212nd Department of Anesthesiology, School of Medicine, University of Athens, Pain Clinic, Attikon University Hospital, 2Thalassemia Unit, General Hospital of Nikaia Ag ...
Lyrakos GN +3 more
doaj
Molecular Oncology, EarlyView.PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source